Herbas VPB

Print
EN | LT
LT - Junginiai, skirti vėžio gydymui
EN - COMPOUNDS FOR THE TREATMENT OF CANCER

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A01N 43/64 (2006.01)
A61K 31/41 (2006.01)
C07D 233/02 (2006.01)
C07D 233/22 (2006.01)
C07D 233/54 (2006.01)
C07D 263/06 (2006.01)
C07D 263/14 (2006.01)
C07D 277/04 (2006.01)
C07D 401/04 (2006.01)
C07D 401/06 (2006.01)
C07D 413/04 (2006.01)
C07D 413/06 (2006.01)
C07D 417/06 (2006.01)
A61K 31/4178 (2006.01)
A61K 31/422 (2006.01)
A61K 31/427 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 2303021
(13) Kind of document T
(96) European patent application number 09835407.9
Date of filing the European patent application 2009-06-16
(97) Date of publication of the European application 2011-04-06
(45) Date of publication and mention of the grant of the patent 2018-12-19
(46) Date of publication of the claims translation 2019-06-25
PCT application
(86) Number PCT/US2009/047572
Date 2009-06-16
PCT application publication
(87) Number WO 2010/074776
Date 2010-07-01
Priority applications
(30) Number Date Country code
61875 P 2008-06-16 US
Inventors
(72)
MILLER, Duane, D., US
LI, Wei, US
WANG, Zhao, US
LU, Yan, US
CHEN, Jianjun, CN
DALTON, James, T., US
LI, Chien-Ming, US
Grantee
(73) University of Tennessee Research Foundation, 211 Conference Center Building 600 Henley Street, Knoxville, TN 37996, US
Ohio State Innovation Foundation, 1524 North High Street, Columbus, OH 43201, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Junginiai, skirti vėžio gydymui
  COMPOUNDS FOR THE TREATMENT OF CANCER
Last renewal fee
Payment date Validity (years) Amount
2020-05-21 12 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2021-06-16